Identification of COX17 as a Therapeutic Target for Non-Small Cell Lung Cancer

Cancer Research

Volumn 63, Issue 21, 2003, Pages 7038-7041

  Suzuki, Chie ^a   Daigo, Yataro ^a   Kikuchi, Takefumi ^a   Katagiri, Toyomasa ^a   Nakamura, Yusuke ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYTOCHROME C OXIDASE; GENE PRODUCT; PROTEIN COX17; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACID SEQUENCE; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CARRIER PROTEINS; CATION TRANSPORT PROTEINS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; ELECTRON TRANSPORT COMPLEX IV; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES, ANTISENSE; RNA, SMALL INTERFERING;

EID: 0242526157     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. American Cancer Society. Cancer Facts and Figures 2001 (Am. Chem. Soc. Atlanta), 2001.
2. Fry, W. A., Phillips, J. L., and Menck, H. R. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer (Phila.), 86: 1867-1876, 1999.
3. Alberti, W., Anderson, G., Bartolucci, A., Bell, D., Villalba, J. B., Brodin, O., Cardiello, C., Cartei, F., Cartei, G., Cellerino, R. et al. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ. 311: 899-909, 1995.
4. Kris M. N. R., and Herbst, R. S A phase II trial of ZD1839 ('Iressa') in advanced non-small cell lung cancer (NSCLC) patients who had failed platinum- and docetaxel-based regimens (IDEAL 2). Proc. Am. Soc. Clin. Oncol. 21: 292a, 2002.
5. Kikuchi, T., Daigo, Y., Katagiri, T., Tsunoda, T., Okada, K., Kakiuchi, S., Zembutsu, H., Furukawa, Y., Kawamura, M., Kobayashi, K., Imai, K., and Nakamura, Y. Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene, 22: 2192-205, 2003.
6. Huffman, D. L., and O'Halloran, T. V. Function, structure, and mechanism of intracellular copper trafficking proteins. Annu. Rev. Biochem., 70: 677-701, 2001.
7. Glerum, D. M., Shtanko, A., and Tzagoloff, A. Characterization of COX17, a yeast gene involved in copper metabolism and assembly of cytochrome oxidase. J. Biol. Chem., 271: 14504-14509, 1996.
8. Amaravadi, R., Glerum. D. M., and Tzagoloff, A. Isolation of a cDNA encoding the human homolog of COX17, a yeast gene essential for mitochondrial copper recruitment. Hum. Genet., 99: 329-333, 1997.
9. Takenouchi, T., Fujimoto, M., Shimamoto, A., and Munekata, E. Isolation and characterization of Cox17p from porcine heart by determining its survival-promoting activity in NIH3T3 cells. Biochim. Biophys. Acta., 1472: 498-508, 1999.
10. Kako, K., Tsumori, K., Ohmasa, Y., Takahashi, Y., and Munekata, E. The expression of Cox17p in rodent tissues and cells. Eur. J. Biochem., 267: 6699-707, 2000.
11. Akashi, H., Han, H. J., Iizaka, M., and Nakamura, Y. Growth-suppressive effect of non-steroidal anti-inflammatory drugs on 11 colon-cancer cell lines and fluorescence differential display of genes whose expression is influenced by sulindac. Int. J. Cancer. 88: 873-880, 2000.
12. Shimokawa, T., Furukawa, Y., Sakai, M., Li, M., Miwa, N., Lin, Y-M., and Nakamura, Y. Involvement of FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the β-catenin/Tcf complex. Cancer Res., in press, 2003.
13. Unoki, M., and Nakamura, Y. EGR2 induces apoptosis in various cancer cell lines by direct transactivation of BNIP3L and BAK. Oncogene, 22: 2172-2185, 2003.
14. Giaccone, G. Clinical impact of novel treatment strategies. Oncogene, 21: 6970-6981, 2002.
15. Kakiuchi, S., Daigo, Y., Tsunoda, T., Yano, S., Sone, S., and Nakamura, Y. Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice. Mol. Cancer Res., 1: 485-499, 2003.
16. Jansen, B., and Zangemeister-Wittke, U. Antisense therapy for cancer - the time of truth. Lancet. Oncol., 3: 672-683. 2002.
17. Brummelkamp, T. R., Bernards, R., and Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science (Wash. DC), 296: 550-553, 2002.
18. Capaldi, R. A. Structure and function of cytochrome c oxidase. Annu. Rev. Biochem., 59: 569-596, 1990.
19. Tsukihara, T., Aoyama, H., Yamashita, E., Tomizaki, T., Yamaguchi, H., Shinzawa-Itoh, K., Nakashima, R., Yaono, R., and Yoshikawa, S. Structures of metal sites of oxidized bovine heart cytochrome c oxidase at 2.8 A. Science (Wash. DC), 269: 1069-1074, 1995.